Milestone Pharmaceuticals Inc.

NasdaqGS:MIST Stock Report

Market Cap: US$179.6m

Milestone Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:MIST Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Apr 26SellUS$82,437Joseph OlivetoIndividual36,500US$2.28
15 Dec 25SellUS$124,273Lorenz MullerIndividual53,566US$2.32
15 Dec 25SellUS$308,685Joseph OlivetoIndividual133,054US$2.32
15 Dec 25SellUS$134,576Amit HasijaIndividual58,007US$2.32
15 Dec 25SellUS$134,576David BharuchaIndividual58,007US$2.32
15 Dec 25SellUS$134,576Jeffrey NelsonIndividual58,007US$2.32

Insider Trading Volume

Insider Buying: MIST insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of MIST?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,125,3200.827%
Institutions28,348,35520.8%
General Public106,576,64178.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 105%.

Top Shareholders

Top 25 shareholders own 19.69% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
4.65%
RTW Investments, LP
6,331,001US$8.4m153%0.07%
1.92%
Propel Bio Management, LLC
2,611,916US$3.4m-36.6%2.77%
1.7%
Two Sigma Investments, LP
2,317,176US$3.1m53%no data
1.47%
The Goldman Sachs Group, Inc.
2,000,025US$2.6m0%no data
1.43%
Marshall Wace LLP
1,944,530US$2.6m17.4%no data
1.14%
Millennium Management LLC
1,544,325US$2.0m284%no data
1.11%
Simplify Asset Management Inc.
1,506,405US$2.0m0%0.03%
0.8%
Point72 Asset Management, L.P.
1,085,683US$1.4m125%no data
0.63%
Balyasny Asset Management L.P.
851,325US$1.1m0%no data
0.6%
Lion Point Capital, LP
820,000US$1.1m8.61%3.62%
0.55%
The Toronto-Dominion Bank
750,000US$990.0k0%no data
0.53%
Morgan Stanley
724,141US$955.9k-7.38%no data
0.49%
Boxer Capital Management, LLC
666,666US$880.0k0%0.09%
0.38%
Susquehanna International Group, LLP
519,046US$685.1k-19.3%no data
0.36%
UBS Asset Management AG
494,908US$653.3k0.62%no data
0.33%
Joseph Oliveto
446,244US$589.0k-7.56%no data
0.25%
Squarepoint OPS LLC
336,825US$444.6k35.1%no data
0.25%
Seven Fleet Capital Management LP
333,333US$440.0k0%0.11%
0.21%
Aptus Capital Advisors, LLC
280,250US$369.9k6.48%no data
0.21%
Guardian Wealth Advisors, LLC
280,250US$369.9k6.48%0.02%
0.15%
Lorenz Muller
205,406US$271.1k36.9%no data
0.14%
Citadel Advisors LLC
196,696US$259.6k-44.3%no data
0.14%
LPL Financial LLC
193,373US$255.2k35.7%no data
0.13%
BNP Paribas Financial Markets SNC
176,504US$233.0k-20.5%no data
0.12%
Boothbay Fund Management, LLC
168,675US$222.7k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/06 02:58
End of Day Share Price 2026/07/06 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Milestone Pharmaceuticals Inc. is covered by 9 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Patrick TrucchioH.C. Wainwright & Co.
Brandon FolkesH.C. Wainwright & Co.
Christopher HowertonJefferies LLC